These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 37037733

  • 21. Cost-utility of quadrivalent versus trivalent influenza vaccine in Brazil - comparison of outcomes from different static model types.
    Van Bellinghen LA, Marijam A, Tannus Branco de Araujo G, Gomez J, Van Vlaenderen I.
    Braz J Infect Dis; 2018; 22(1):1-10. PubMed ID: 29352897
    [Abstract] [Full Text] [Related]

  • 22. Cost-Effectiveness of Routine Childhood Vaccination Against Seasonal Influenza in Germany.
    Scholz SM, Weidemann F, Damm O, Ultsch B, Greiner W, Wichmann O.
    Value Health; 2021 Jan; 24(1):32-40. PubMed ID: 33431151
    [Abstract] [Full Text] [Related]

  • 23. Cost-effectiveness analysis of quadrivalent influenza vaccination in at-risk adults and the elderly: an updated analysis in the U.K.
    Meier G, Gregg M, Poulsen Nautrup B.
    J Med Econ; 2015 Jan; 18(9):746-61. PubMed ID: 25903831
    [Abstract] [Full Text] [Related]

  • 24. Vaccine effectiveness of live attenuated and trivalent inactivated influenza vaccination in 2010/11 to 2015/16: the SIVE II record linkage study.
    Simpson CR, Lone NI, Kavanagh K, Englishby T, Robertson C, McMenamin J, Wissman BV, Vasileiou E, Butler CC, Ritchie LD, Gunson R, Schwarze J, Sheikh A.
    Health Technol Assess; 2020 Dec; 24(67):1-66. PubMed ID: 33256892
    [Abstract] [Full Text] [Related]

  • 25. Cost-Effectiveness of Quadrivalent versus Trivalent Influenza Vaccine in the United States.
    de Boer PT, Crépey P, Pitman RJ, Macabeo B, Chit A, Postma MJ.
    Value Health; 2016 Dec; 19(8):964-975. PubMed ID: 27987647
    [Abstract] [Full Text] [Related]

  • 26. [Cost-effectiveness analysis of quadrivalent influenza vaccination for older adults aged 60 and above in mainland China].
    Yan H, Yang J, Chen ZY, Gong H, Zhong GJ, Yu HJ.
    Zhonghua Yi Xue Za Zhi; 2021 Aug 10; 101(30):2405-2412. PubMed ID: 34404135
    [Abstract] [Full Text] [Related]

  • 27. Public health impact and cost-effectiveness of intranasal live attenuated influenza vaccination of children in Germany.
    Damm O, Eichner M, Rose MA, Knuf M, Wutzler P, Liese JG, Krüger H, Greiner W.
    Eur J Health Econ; 2015 Jun 10; 16(5):471-88. PubMed ID: 24859492
    [Abstract] [Full Text] [Related]

  • 28. Assessment of Public Health and Economic Impact of Intranasal Live-Attenuated Influenza Vaccination of Children in France Using a Dynamic Transmission Model.
    Gerlier L, Lamotte M, Grenèche S, Lenne X, Carrat F, Weil-Olivier C, Damm O, Schwehm M, Eichner M.
    Appl Health Econ Health Policy; 2017 Apr 10; 15(2):261-276. PubMed ID: 27943165
    [Abstract] [Full Text] [Related]

  • 29. Cost-effectiveness and public health impact of alternative influenza vaccination strategies in high-risk adults.
    Raviotta JM, Smith KJ, DePasse J, Brown ST, Shim E, Nowalk MP, Wateska A, France GS, Zimmerman RK.
    Vaccine; 2017 Oct 09; 35(42):5708-5713. PubMed ID: 28890196
    [Abstract] [Full Text] [Related]

  • 30. [Technical guidelines for seasonal influenza vaccination in China (2020-2021)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) Influenza Vaccination TWG.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Oct 10; 41(10):1555-1576. PubMed ID: 33297613
    [Abstract] [Full Text] [Related]

  • 31. A cost-effectiveness analysis of South Africa's seasonal influenza vaccination programme.
    Edoka I, Kohli-Lynch C, Fraser H, Hofman K, Tempia S, McMorrow M, Ramkrishna W, Lambach P, Hutubessy R, Cohen C.
    Vaccine; 2021 Jan 08; 39(2):412-422. PubMed ID: 33272702
    [Abstract] [Full Text] [Related]

  • 32. [Technical guidelines for seasonal influenza vaccination in China (2020-2021)].
    National Immunization Advisory Committee Technical Working Group.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Oct 06; 54(10):1035-1059. PubMed ID: 33131228
    [Abstract] [Full Text] [Related]

  • 33. Cost-utility analysis of increasing uptake of universal seasonal quadrivalent influenza vaccine (QIV) in children aged 6 months and older in Germany.
    Molnar D, Anastassopoulou A, Poulsen Nautrup B, Schmidt-Ott R, Eichner M, Schwehm M, Dos Santos G, Ultsch B, Bekkat-Berkani R, von Krempelhuber A, Van Vlaenderen I, Van Bellinghen LA.
    Hum Vaccin Immunother; 2022 Nov 30; 18(5):2058304. PubMed ID: 35486410
    [Abstract] [Full Text] [Related]

  • 34. [Technical guidelines for seasonal influenza vaccination in China (2021-2022)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) , Influenza Vaccination TWG.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Oct 10; 42(10):1722-1749. PubMed ID: 34814607
    [Abstract] [Full Text] [Related]

  • 35. Cost-Effectiveness and Public Health Effect of Influenza Vaccine Strategies for U.S. Elderly Adults.
    Raviotta JM, Smith KJ, DePasse J, Brown ST, Shim E, Nowalk MP, Zimmerman RK.
    J Am Geriatr Soc; 2016 Oct 10; 64(10):2126-2131. PubMed ID: 27709600
    [Abstract] [Full Text] [Related]

  • 36. The cost-effectiveness of trivalent and quadrivalent influenza vaccination in communities in South Africa, Vietnam and Australia.
    de Boer PT, Kelso JK, Halder N, Nguyen TP, Moyes J, Cohen C, Barr IG, Postma MJ, Milne GJ.
    Vaccine; 2018 Feb 08; 36(7):997-1007. PubMed ID: 29373192
    [Abstract] [Full Text] [Related]

  • 37. Cost-utility analysis of influenza vaccination in a population aged 65 years or older in Spain with a high-dose vaccine versus an adjuvanted vaccine.
    Redondo E, Drago G, López-Belmonte JL, Guillén JM, Bricout H, Alvarez FP, Callejo D, Gil de Miguel Á.
    Vaccine; 2021 Aug 23; 39(36):5138-5145. PubMed ID: 34344553
    [Abstract] [Full Text] [Related]

  • 38. The comparative value of various employer-sponsored influenza vaccination clinics.
    Zimmerman RK, Wiringa AE, Nowalk MP, Lin CJ, Rousculp MD, Mitgang EA, Lee BY.
    J Occup Environ Med; 2012 Sep 23; 54(9):1107-17. PubMed ID: 22929797
    [Abstract] [Full Text] [Related]

  • 39. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022-23 Influenza Season.
    Grohskopf LA, Blanton LH, Ferdinands JM, Chung JR, Broder KR, Talbot HK, Morgan RL, Fry AM.
    MMWR Recomm Rep; 2022 Aug 26; 71(1):1-28. PubMed ID: 36006864
    [Abstract] [Full Text] [Related]

  • 40. Cost-effectiveness of high-dose versus standard-dose inactivated influenza vaccine in adults aged 65 years and older: an economic evaluation of data from a randomised controlled trial.
    Chit A, Becker DL, DiazGranados CA, Maschio M, Yau E, Drummond M.
    Lancet Infect Dis; 2015 Dec 26; 15(12):1459-66. PubMed ID: 26362172
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.